Literature DB >> 12414751

Tumor necrosis factor gene polymorphisms, leukocyte function, and sepsis susceptibility in blunt trauma patients.

Matthias Majetschak1, Udo Obertacke, F Ulrich Schade, Mark Bardenheuer, Gregor Voggenreiter, Brunhilde Bloemeke, Michael Heesen.   

Abstract

The tumor necrosis factor alpha (TNF-alpha) -308 G/A and TNF-beta NcO1 polymorphisms have been described to be associated with an increased risk for sepsis in critically ill patients. Functional consequences associated with these polymorphisms remain unclear. We compared the genotype distribution of these TNF polymorphisms with susceptibility to severe sepsis and leukocyte function in blunt trauma patients (n = 70; mean injury severity score, 24 points [range, 4 to 57). Severe sepsis was defined according to the American College of Chest Physicians-Society of Critical Care Medicine consensus conference criteria. Genotyping for the NcO1 polymorphism (alleles TNFB1 and TNFB2) was performed by PCR and digestion of the products with NcO1, and that for the TNF-alpha -308 G/A polymorphism (alleles TNF1 and TNF2) was performed by real-time PCR. Leukocyte function was assessed by measurement of the production of endotoxin-induced cytokines (TNF-alpha, interleukin-6 [IL-6], and IL-8) in whole blood. TNF-alpha, IL-6, and IL-8 were determined by enzyme-linked immunosorbent assay. For the genotypes of the TNF-alpha -308 G/A polymorphism, differences in the frequency of development of severe sepsis were not detectable. Patients developing severe sepsis after trauma were significantly more likely to possess a homozygous genotype of the TNF-beta NcO1 polymorphism. Compared with heterozygotes, the odds ratio for the TNFB2/B2 genotype for the development of severe posttraumatic sepsis was 11 (P = 0.01), and that for the TNFB1/B1 genotype was 13 (P = 0.014). TNF-alpha -308:TNF-beta NcO1 haplotype analysis showed that the TNFB2:TNF2 haplotype is significantly negatively associated with development of severe sepsis. Patients homozygous for the TNFB1 or TNFB2 allele showed a persistently higher cytokine-producing capacity during at least 4 to 8 days after trauma than the heterozygotes. In patients homozygous for the TNF1 allele, a higher TNF-alpha- and IL-8-producing capacity was found only at day 1 after trauma. Although the TNF-beta NcO1 polymorphism appears to be less likely to be causative for development of severe sepsis after trauma, it is thus far the only genetic marker identified which can be used as a relevant risk estimate for severe sepsis in trauma patients immediately after the injury.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12414751      PMCID: PMC130126          DOI: 10.1128/cdli.9.6.1205-1211.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  43 in total

1.  The -308 tumor necrosis factor-alpha promoter polymorphism effects transcription.

Authors:  K M Kroeger; K S Carville; L J Abraham
Journal:  Mol Immunol       Date:  1997-04       Impact factor: 4.407

Review 2.  Cachectin: more than a tumor necrosis factor.

Authors:  B Beutler; A Cerami
Journal:  N Engl J Med       Date:  1987-02-12       Impact factor: 91.245

Review 3.  Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease.

Authors:  L J Abraham; K M Kroeger
Journal:  J Leukoc Biol       Date:  1999-10       Impact factor: 4.962

4.  Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans.

Authors:  E Louis; D Franchimont; A Piron; Y Gevaert; N Schaaf-Lafontaine; S Roland; P Mahieu; M Malaise; D De Groote; R Louis; J Belaiche
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

5.  The interleukin-6 G(-174)C polymorphism and the ex vivo interleukin-6 response to endotoxin in severely injured blunt trauma patients.

Authors:  Michael Heesen; Udo Obertacke; F Ulrich Schade; Brunhilde Bloemeke; Matthias Majetschak
Journal:  Eur Cytokine Netw       Date:  2002 Jan-Mar       Impact factor: 2.737

6.  Distribution of tumor necrosis factor alleles (NcoI RFLP) and their relationship to HLA haplotypes in an Italian population.

Authors:  D Peruccio; S D'Alfonso; I Borelli; A Amoroso; G Mazzola; D Marsico; M Bersanti; P Richiardi
Journal:  Hum Hered       Date:  1993 Mar-Apr       Impact factor: 0.444

7.  Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria.

Authors:  W McGuire; A V Hill; C E Allsopp; B M Greenwood; D Kwiatkowski
Journal:  Nature       Date:  1994-10-06       Impact factor: 49.962

8.  Tumour necrosis factor B gene polymorphism in relation to complotype in couples with spontaneous abortions and in control families.

Authors:  T Laitinen; M L Lokki; M Tulppala; O Ylikorkala; S Koskimies
Journal:  Scand J Immunol       Date:  1992-02       Impact factor: 3.487

9.  Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation.

Authors:  A G Wilson; J A Symons; T L McDowell; H O McDevitt; G W Duff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

10.  Functional analysis of a new polymorphism in the human TNF alpha gene promoter.

Authors:  F Pociot; S D'Alfonso; S Compasso; R Scorza; P M Richiardi
Journal:  Scand J Immunol       Date:  1995-10       Impact factor: 3.487

View more
  23 in total

1.  Maternal pro-inflammatory state during pregnancy and newborn leukocyte telomere length: A prospective investigation.

Authors:  Claudia Lazarides; Elissa S Epel; Jue Lin; Elizabeth H Blackburn; Manuel C Voelkle; Claudia Buss; Hyagriv N Simhan; Pathik D Wadhwa; Sonja Entringer
Journal:  Brain Behav Immun       Date:  2019-04-08       Impact factor: 7.217

2.  A nonsynonymous polymorphism of IRAK4 associated with increased prevalence of gram-positive infection and decreased response to toll-like receptor ligands.

Authors:  Ainsley M Sutherland; Keith R Walley; Taka-Aki Nakada; Andy H P Sham; Mark M Wurfel; James A Russell
Journal:  J Innate Immun       Date:  2011-05-14       Impact factor: 7.349

Review 3.  Early Diagnosis of Sepsis: Is an Integrated Omics Approach the Way Forward?

Authors:  Raymond J Langley; Hector R Wong
Journal:  Mol Diagn Ther       Date:  2017-10       Impact factor: 4.074

4.  Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.

Authors:  Ana Paula Kallaur; Josiane Lopes; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Edna Maria Vissoci Reiche; Elaine Regina Delicato de Almeida; Helena Kaminami Morimoto; Wildea Lice Carvalho Jennings de Pereira; Daniele Frizon Alfieri; Sueli Donizete Borelli; Domacio Ramon Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2015-09-24       Impact factor: 5.590

5.  Ethical considerations in the collection of genetic data from critically ill patients: what do published studies reveal about potential directions for empirical ethics research?

Authors:  B D Freeman; C R Kennedy; H L Frankel; B Clarridge; D Bolcic-Jankovic; E Iverson; E Shehane; A Celious; B A Zehnbauer; T G Buchman
Journal:  Pharmacogenomics J       Date:  2009-12-08       Impact factor: 3.550

6.  Association of tumor necrosis factor β genetic polymorphism and sepsis susceptibility.

Authors:  Francieli Delongui; Cíntia Magalhães Carvalho Grion; Maria Angelica Ehara Watanabe; Helena Kaminami Morimoto; Ana Maria Bonametti; Julie Massayo Maeda Oda; Ana Paula Kallaur; Tiemi Matsuo; Edna Maria Reiche
Journal:  Exp Ther Med       Date:  2011-01-20       Impact factor: 2.447

7.  An Enrichment Strategy Yields Seven Novel Single Nucleotide Polymorphisms Associated With Mortality and Altered Th17 Responses Following Blunt Trauma.

Authors:  Lukas Schimunek; Rami A Namas; Jinling Yin; Dongmei Liu; Derek Barclay; Fayten El-Dehaibi; Andrew Abboud; Haley Lindberg; Ruben Zamora; Timothy R Billiar; Yoram Vodovotz
Journal:  Shock       Date:  2018-03       Impact factor: 3.454

8.  Genetic, Immune-Inflammatory, and Oxidative Stress Biomarkers as Predictors for Disability and Disease Progression in Multiple Sclerosis.

Authors:  Ana Paula Kallaur; Edna Maria Vissoci Reiche; Sayonara Rangel Oliveira; Andrea Name Colado Simão; Wildea Lice de Carvalho Jennings Pereira; Daniela Frizon Alfieri; Tamires Flauzino; Caio de Meleck Proença; Marcell Alysson Batisti Lozovoy; Damacio Ramón Kaimen-Maciel; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-01-05       Impact factor: 5.590

9.  Functional significance of gene polymorphisms in the promoter of myeloid differentiation-2.

Authors:  Wei Gu; You-an Shan; Jian Zhou; Dong-po Jiang; Lianyang Zhang; Ding-yuan Du; Zheng-guo Wang; Jian-xin Jiang
Journal:  Ann Surg       Date:  2007-07       Impact factor: 12.969

10.  TNF-α, IL-6, and IL-8 cytokines and their association with TNF-α-308 G/A polymorphism and postoperative sepsis.

Authors:  Kavita Baghel; Rajeshwar Nath Srivastava; Abhijit Chandra; Sudhir K Goel; Jyotsna Agrawal; Hasan Raza Kazmi; Saloni Raj
Journal:  J Gastrointest Surg       Date:  2014-06-19       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.